Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.56 Billion CNY | -8.69% |
| 2022 | 3.89 Billion CNY | 6.98% |
| 2021 | 3.64 Billion CNY | 303.85% |
| 2020 | 902.51 Million CNY | 24.37% |
| 2019 | 725.67 Million CNY | 171.67% |
| 2018 | 267.11 Million CNY | 40.85% |
| 2017 | 189.65 Million CNY | 18.45% |
| 2016 | 160.11 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.37 Billion CNY | -3.23% |
| 2024 Q1 | 3.48 Billion CNY | -2.11% |
| 2024 Q3 | 3.41 Billion CNY | 1.13% |
| 2023 Q1 | 3.7 Billion CNY | -5.01% |
| 2023 Q2 | 3.7 Billion CNY | -0.07% |
| 2023 Q4 | 3.56 Billion CNY | -1.21% |
| 2023 Q3 | 3.6 Billion CNY | -2.62% |
| 2023 FY | 3.56 Billion CNY | -8.69% |
| 2022 Q4 | 3.89 Billion CNY | -0.74% |
| 2022 Q3 | 3.92 Billion CNY | 1.89% |
| 2022 Q1 | 3.92 Billion CNY | 7.6% |
| 2022 Q2 | 3.85 Billion CNY | -1.68% |
| 2022 FY | 3.89 Billion CNY | 6.98% |
| 2021 Q2 | 2.57 Billion CNY | 10.15% |
| 2021 Q1 | 2.34 Billion CNY | 159.52% |
| 2021 FY | 3.64 Billion CNY | 303.85% |
| 2021 Q3 | 2.4 Billion CNY | -6.93% |
| 2021 Q4 | 3.64 Billion CNY | 51.8% |
| 2020 FY | 902.51 Million CNY | 24.37% |
| 2020 Q2 | 706.2 Million CNY | -6.43% |
| 2020 Q3 | 686.02 Million CNY | -2.86% |
| 2020 Q4 | 902.51 Million CNY | 31.56% |
| 2020 Q1 | 754.7 Million CNY | 4.0% |
| 2019 Q1 | 261.6 Million CNY | -2.06% |
| 2019 FY | 725.67 Million CNY | 171.67% |
| 2019 Q4 | 725.67 Million CNY | 3.96% |
| 2019 Q3 | 698.02 Million CNY | 142.06% |
| 2019 Q2 | 288.37 Million CNY | 10.23% |
| 2018 Q4 | 267.11 Million CNY | 0.0% |
| 2018 FY | 267.11 Million CNY | 40.85% |
| 2017 FY | 189.65 Million CNY | 18.45% |
| 2016 FY | 160.11 Million CNY | 0.0% |